Have you been recently diagnosed with Acute Lymphoblastic Leukemia? If so, you may be able to take part in a research study to help us learn more about the effects of using Tyrosine Kinase Inhibitor (TKI), steroids and blinatumomab versus treatment with steroids, Tyrosine Kinase Inhibitor (TKI) and chemotherapy.

To evaluate the safety and efficacy of BLU-222 therapy in patients with advanced solid tumors.

Do you plan to undergo radiation therapy for a cancer in the abdomen or pelvic region? You may be able to take part in a research study to help us learn if a fatty acid supplement can improve quality of life by limiting GI upset during radiation therapy.

Do you have stage 1, HER2-positive breast cancer? Has your surgery already been completed? If so, you may be able to take part in a study to help us learn more about a combination of medications to treat your cancer.

Do you have metastatic or recurrent lung cancer? Have you already been treated with chemotherapy or immunotherapy? If so, you may qualify for the LungMap protocol, which will help us identify clinical trials you may be eligible for.

This is a study to learn more about the safety and effectiveness of PT217 to treat advanced cancers. We are looking for patients with small cell lung cancer, large cell neuroendocrine cancer, neuroendocrine prostate cancer or gastroenteropancreatic neuroendocrine carcinomas to take part.

Have you been diagnosed with Advanced Renal Cell Carcinoma? If so, you may be able to take part in a research study investigating the optimal way to combine or sequence therapies in patients with renal cell cancer with bone metastasis.

Many students have beliefs about intelligence that can relate to their academic performance. Therefore, the purpose of this study is to investigate if the way students learn and adapt in the classroom varies as a function of their beliefs. Research on how beliefs influence student performance is sorely needed and of high priority.

There is very little knowledge about why Chinese-speaking Asians develop eating disorders. In this study, we want to understand the symptoms and genetic risks of eating disorders among Chinese-speaking Asians.

This is a phase III trial to compare the usual treatment for Locally Advanced Non-Small Cell Lung Cancer to the use of stereotactic body radiation therapy (SBRT) in addition to the usual treatment. SBRT is already commonly used in lung cancer treatment, but it has not routinely been added to the usual combination of radiation, chemotherapy, and immune therapy that doctors normally use. This study will help the study doctors find out if this different approach is better, the same, or worse than the usual approach.